Company Filing History:
2 out of 5 
2 out of 4 Years Active: 2021-2023
Title: Gene-Errol Eugenio Ringpis: Innovator in Gene Therapy
Introduction
Gene-Errol Eugenio Ringpis is a notable inventor based in West Hollywood, CA, who has made significant contributions to the field of gene therapy. With a total of two patents to his name, he is recognized for his innovative approaches to treating beta-hemoglobinopathies, including sickle cell disease and β-thalassemia.
Latest Patents
His latest patents focus on compositions and methods for treating beta-hemoglobinopathies. The disclosures provide expression vectors that comprise at least two nucleic acid sequences: one encoding an anti-HPRT RNAi and another encoding a gamma globin gene. In some embodiments, the viral vector utilized is a self-inactivating lentiviral vector. The gamma-globin gene is employed to genetically correct sickle cell disease or β-thalassemia or to alleviate symptoms associated with these conditions.
Career Highlights
Gene-Errol has worked with prominent companies in the field, including CSL Behring Gene Therapy, Inc. and CSL Gene Therapy Pty Ltd. His work has been pivotal in advancing gene therapy techniques and improving treatment options for patients suffering from genetic blood disorders.
Collaborations
Throughout his career, Gene-Errol has collaborated with esteemed colleagues such as Jeffrey Ahlers and Jeffrey S. Bartlett. These collaborations have further enhanced his research and development efforts in gene therapy.
Conclusion
Gene-Errol Eugenio Ringpis stands out as an influential inventor in the realm of gene therapy, with a focus on innovative solutions for treating serious blood disorders. His contributions continue to pave the way for advancements in medical science and patient care.